INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin
Crossref DOI link: https://doi.org/10.1007/s00415-017-8698-2
Published Online: 2017-12-21
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Misra, Vijay P.
,
Colosimo, Carlo
Charles, David
Chung, Tae Mo
Maisonobe, Pascal
Om, Savary
Funding for this research was provided by:
Ipsen Pharma
License valid from 2017-12-21